These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Therapeutic immunization with radio-attenuated Leishmania parasites through i.m. route revealed protection against the experimental murine visceral leishmaniasis. Datta S; Manna M; Khanra S; Ghosh M; Bhar R; Chakraborty A; Roy S Parasitol Res; 2012 Jul; 111(1):361-9. PubMed ID: 22437790 [TBL] [Abstract][Full Text] [Related]
8. Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice. Thakur A; Kaur H; Kaur S Immunobiology; 2015 Sep; 220(9):1031-8. PubMed ID: 26001730 [TBL] [Abstract][Full Text] [Related]
9. Ubiquitin conjugation of open reading frame F DNA vaccine leads to enhanced cell-mediated immune response and induces protection against both antimony-susceptible and -resistant strains of Leishmania donovani. Sharma A; Madhubala R J Immunol; 2009 Dec; 183(12):7719-31. PubMed ID: 19933862 [TBL] [Abstract][Full Text] [Related]
10. gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani. Bhowmick S; Ravindran R; Ali N Infect Immun; 2008 Mar; 76(3):1003-15. PubMed ID: 18195029 [TBL] [Abstract][Full Text] [Related]
11. Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis. Das P; Paik D; Naskar K; Chakraborti T Microbes Infect; 2018 Jan; 20(1):37-47. PubMed ID: 28970116 [TBL] [Abstract][Full Text] [Related]
12. Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasis. Nagill R; Mahajan R; Sharma M; Kaur S Parasitol Int; 2009 Dec; 58(4):359-66. PubMed ID: 19638322 [TBL] [Abstract][Full Text] [Related]
13. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice. Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the immunogenicity and protective efficacy of killed Leishmania donovani antigen along with different adjuvants against experimental visceral leishmaniasis. Thakur A; Kaur H; Kaur S Med Microbiol Immunol; 2015 Aug; 204(4):539-50. PubMed ID: 25432859 [TBL] [Abstract][Full Text] [Related]
16. Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route. Ravindran R; Maji M; Ali N Mol Pharm; 2012 Jan; 9(1):59-70. PubMed ID: 22133194 [TBL] [Abstract][Full Text] [Related]
17. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. Melby PC; Yang J; Zhao W; Perez LE; Cheng J Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143 [TBL] [Abstract][Full Text] [Related]
18. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10. Bhaumik SK; Naskar K; De T Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis. Thakur A; Kaur H; Kaur S Parasitol Int; 2015 Feb; 64(1):70-8. PubMed ID: 25316605 [TBL] [Abstract][Full Text] [Related]
20. Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice. Elikaee S; Mohebali M; Rezaei S; Eslami H; Khamesipour A; Keshavarz H; Eshraghian MR Vaccine; 2019 May; 37(24):3221-3228. PubMed ID: 31047672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]